ArticleInvestigative ophthalmology & visual science2026
SPARC Promotes Corneal Epithelial Wound Healing Through β-catenin Nuclear Translocation and c-Met Activation.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the molecular mechanism through which secreted protein acidic and rich in cysteine (SPARC) facilitates corneal epithelial wound healing via the β-catenin/c-Met signaling pathway. Methods: Wild-type C57BL/6 mice, Sparc-/- mice, and human corneal epithelial cells (HCECs) were used. Corneal epithelial repair was assessed by sodium fluorescein staining, hematoxylin and eosin staining, EdU incorporation, and Cell Counting Kit-8 assays. SPARC- and pathway-related changes were evaluated by quantitative RT-PCR, immunofluorescence, Western blotting, and flow cytometry. β-Catenin-c-Met interaction was analyzed by co-immunoprecipitation. Tandem mass tag-based phosphoproteomics compared phosphorylation profiles between control and exogenous SPARC-treated groups. Results: In vivo and in vitro analyses showed that SPARC promoted corneal epithelial wound healing. SPARC deficiency delayed epithelial closure, reduced epithelial thickness, and impaired epithelial-stromal adhesion, whereas exogenous SPARC partially rescued these defects. In HCECs, SPARC knockdown reduced cell proliferation and migration. Mechanistically, SPARC loss decreased β-catenin expression and nuclear translocation, downregulated c-Myc, and reduced c-Met mRNA expression, total protein abundance, and phosphorylation. Silencing either β-catenin or Met impaired epithelial repair, whereas exogenous SPARC or pathway agonists partially restored these phenotypes. Co-immunoprecipitation further showed that SPARC deficiency weakened the interaction between β-catenin and c-Met. Conclusions: SPARC promotes corneal epithelial wound healing by enhancing β-catenin nuclear translocation and c-Met activation, thereby promoting epithelial proliferation and migration. The SPARC-β-catenin-c-Met axis may represent a therapeutic target for corneal epithelial injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.